Navigation Links
Immune system molecule promotes tumor resistance to anti-angiogenic therapy
Date:8/5/2013

A team of scientists, led by Napoleone Ferrara, MD, has shown for the first time that a signaling protein involved in inflammation also promotes tumor resistance to anti-angiogenic therapy.

The findings by Ferrara professor of pathology at the University of California, San Diego School of Medicine and senior deputy director for basic science at the UC San Diego Moores Cancer Center and colleagues at Genentech, a biotechnology firm based in South San Francisco, are published in the August 4 Advance Online Publication of the journal Nature Medicine.

Angiogenesis is a physiological process in which new blood vessels form from existing vessels. It is fundamental to early development and wound healing, but some cancer tumors exploit angiogenesis to promote blood vessel growth and fuel a tumor's transition from a benign to a malignant state.

In the late 1980s, Ferrara led efforts to identify a key gene (VEGF) involved in angiogenesis and subsequent development of the first drugs to block VEGF-mediated growth in a variety of cancers, among them lung, kidney, brain and colorectal. Researchers discovered, however, that similar to other therapies, VEGF-targeting drugs may lose effectiveness as tumors develop resistance, allowing cancers to recur.

The latest research highlights the role of interleukin-17 or IL-17, one of a family of signaling molecules called cytokines that are involved in the body's immune response. Ferrara and colleagues discovered that IL-17 signaling in tumor-infiltrating T cells, part of the body's adaptive immune response, encourages resistance to the VEGF-blockade in mouse models.

"Our work has the potential to have major translational and therapeutic relevance," said Ferrara. "By inhibiting the effects of IL-17 with monoclonal antibodies or other blockers, we can potentially improve the clinical efficacy of VEGF-targeting drugs."


'/>"/>

Contact: Scott LaFee
slafee@ucsd.edu
619-543-6163
University of California - San Diego
Source:Eurekalert

Page: 1

Related medicine news :

1. The American Academy of Anti-Aging Medicine (A4M) to host Gut, Brain, and Autoimmune Disorders: the Role of Food Symposium in Los Angeles, CA August 16-17, 2013
2. Premature aging of immune cells in joints of kids with chronic arthritis, Pitt team says
3. Isolated psychiatric episodes rare, but possible, in common form of autoimmune encephalitis
4. Mount Sinai researchers discover mechanism behind development of autoimmune hepatitis
5. Poor sleep in pregnancy can disrupt the immune system and cause birth-related complications
6. Targeting errant immune system enzyme kills myelodysplastic cells
7. Removal of tumor-associated immune cell protein decreases tumor progression
8. Maintaining immune balance involves an unconventional mechanism of T cell regulation
9. IRCM scientists find a novel research model for the study of auto-immune diseases
10. Scientists discover new mechanism regulating the immune response
11. Modified immune cells seek and destroy melanoma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/17/2019)... ... September 17, 2019 , ... Since ... the 21st Century Cures Act in the US, Nocimed has been marketing its ... Using images from existing MRI equipment to perform MR spectroscopy, NociScan detects ...
(Date:9/17/2019)... , ... September 17, 2019 , ... ... Dental Implants welcome patients with missing teeth in Chattanooga, TN for customized full ... a periodontist in as little as one day, providing a permanent tooth replacement ...
(Date:9/17/2019)... ... 2019 , ... Lubin Austermuehle, P.C. will be one of the ... be held at Found Kitchen and Social House in Evanston on Monday, October 7 ... Neurodevelopmental Disorder, a rare condition that results from changes to the GRIN2B gene. The ...
(Date:9/17/2019)... ... September 17, 2019 , ... Genomenon ... with the goal of providing resources to assist researchers and encourage pharmaceutical companies ... disease causing abnormal iron deposits in the brain. , BPAN Warriors is ...
(Date:9/17/2019)... ... September 17, 2019 , ... ... Open House day on Pacifica's Lambert Campus, 249 Lambert Road, Carpinteria, CA. ... the Humanities, Clinical Psychology, Counseling Psychology, and Mythological Studies. Program Faculty will ...
Breaking Medicine News(10 mins):
(Date:9/17/2019)... EVANSTON, Ill. (PRWEB) , ... September 17, 2019 , ... ... grant from the Gordon and Betty Moore Foundation to launch the DxQI Seed Grant ... test interventions aimed at improving diagnostic quality and reducing harm from diagnostic error. ...
(Date:9/14/2019)... (PRWEB) , ... September 13, 2019 , ... ... of teledentistry services for employers, became the first commercial teledentistry practice in the ... award-winning startup with other hub entrepreneurs, company leaders, innovators and industry experts next ...
(Date:9/14/2019)... ... ... The Allergenic Products Advisory Committee of the Food and Drug Administration (FDA) met today ... a standardized oral immunotherapy (OIT) product for peanut allergy. The brand name is expected ... would require a Risk Evaluation and Mitigation Strategy (REMS) to be developed to help ...
Breaking Medicine Technology: